Obesity and Polycystic Ovary Syndrome
The core pathophysiology of polycystic ovary syndrome involves an overproduction of androgens primarily originating from ovarian thecal cells. Two major external triggers promote androgen overproduction in the ovaries: the increased secretion of luteinizing hormone, a consequence of aberrant hypotha...
Saved in:
Published in | Journal of Obesity & Metabolic Syndrome Vol. 33; no. 4; pp. 289 - 301 |
---|---|
Main Author | |
Format | Journal Article |
Language | English |
Published |
Korea (South)
Korean Society for the Study of Obesity
01.12.2024
대한비만학회 |
Subjects | |
Online Access | Get full text |
ISSN | 2508-6235 2508-7576 2508-7576 |
DOI | 10.7570/jomes24035 |
Cover
Abstract | The core pathophysiology of polycystic ovary syndrome involves an overproduction of androgens primarily originating from ovarian thecal cells. Two major external triggers promote androgen overproduction in the ovaries: the increased secretion of luteinizing hormone, a consequence of aberrant hypothalamic gonadotropin-releasing hormone secretion dynamics, and compensatory hyperinsulinemia resulting from insulin resistance. Obesity interacts with polycystic ovary syndrome in multiple ways, but a major role of obesity in its pathophysiology is the exacerbation of insulin resistance. Additionally, obesity contributes to polycystic ovary syndrome by facilitating the conversion of precursor hormones to testosterone within adipose cells. Moreover, obesity can lead to relative hyperandrogenemia, which is marked by lower levels of sex hormone binding globulin and increased availability of free testosterone to target tissues. Also, obesity affects the secretion of gonadotropins, resulting in heightened luteinizing hormone secretion or increased sensitivity of thecal cells to luteinizing hormone. Obesity-related insulin resistance might be amplified by alterations in adipokine and inflammatory cytokine production. Ultimately, obesity and polycystic ovary syndrome might share a common genetic predisposition. The cornerstone of managing polycystic ovary syndrome is to address individual symptoms such as hyperandrogenism (hirsutism, acne, and female type boldness), menstrual irregularities, and infertility stemming from anovulation. However, obesity is integral to the pathophysiology of polycystic ovary syndrome and exacerbates all of its features. Therefore, lifestyle modifications aimed at weight reduction should be the primary strategy in overweight or obese women with polycystic ovary syndrome. |
---|---|
AbstractList | The core pathophysiology of polycystic ovary syndrome involves an overproduction of androgens primarily originating from ovarian thecal cells. Two major external triggers promote androgen overproduction in the ovaries: the increased secretion of luteinizing hormone, a consequence of aberrant hypothalamic gonadotropin-releasing hormone secretion dynamics, and compensatory hyperinsulinemia resulting from insulin resistance. Obesity interacts with polycystic ovary syndrome in multiple ways, but a major role of obesity in its pathophysiology is the exacerbation of insulin resistance. Additionally, obesity contributes to polycystic ovary syndrome by facilitating the conversion of precursor hormones to testosterone within adipose cells. Moreover, obesity can lead to relative hyperandrogenemia, which is marked by lower levels of sex hormone binding globulin and increased availability of free testosterone to target tissues. Also, obesity affects the secretion of gonadotropins, resulting in heightened luteinizing hormone secretion or increased sensitivity of thecal cells to luteinizing hormone. Obesity-related insulin resistance might be amplified by alterations in adipokine and inflammatory cytokine production. Ultimately, obesity and polycystic ovary syndrome might share a common genetic predisposition. The cornerstone of managing polycystic ovary syndrome is to address individual symptoms such as hyperandrogenism (hirsutism, acne, and female type boldness), menstrual irregularities, and infertility stemming from anovulation. However, obesity is integral to the pathophysiology of polycystic ovary syndrome and exacerbates all of its features. Therefore, lifestyle modifications aimed at weight reduction should be the primary strategy in overweight or obese women with polycystic ovary syndrome. The core pathophysiology of polycystic ovary syndrome involves an overproduction of androgens primarily originating from ovarian thecal cells. Two major external triggers promote androgen overproduction in the ovaries: the increased secretion of luteinizing hormone, a consequence of aberrant hypothalamic gonadotropin-releasing hormone secretion dynamics, and compensatory hyperinsulinemia resulting from insulin resistance. Obesity interacts with polycystic ovary syndrome in multiple ways, but a major role of obesity in its pathophysiology is the exacerbation of insulin resistance. Additionally, obesity contributes to polycystic ovary syndrome by facilitating the conversion of precursor hormones to testosterone within adipose cells. Moreover, obesity can lead to relative hyperandrogenemia, which is marked by lower levels of sex hormone binding globulin and increased availability of free testosterone to target tissues. Also, obesity affects the secretion of gonadotropins, resulting in heightened luteinizing hormone secretion or increased sensitivity of thecal cells to luteinizing hormone. Obesity-related insulin resistance might be amplified by alterations in adipokine and inflammatory cytokine production. Ultimately, obesity and polycystic ovary syndrome might share a common genetic predisposition. The cornerstone of managing polycystic ovary syndrome is to address individual symptoms such as hyperandrogenism (hirsutism, acne, and female type boldness), menstrual irregularities, and infertility stemming from anovulation. However, obesity is integral to the pathophysiology of polycystic ovary syndrome and exacerbates all of its features. Therefore, lifestyle modifications aimed at weight reduction should be the primary strategy in overweight or obese women with polycystic ovary syndrome. KCI Citation Count: 0 The core pathophysiology of polycystic ovary syndrome involves an overproduction of androgens primarily originating from ovarian thecal cells. Two major external triggers promote androgen overproduction in the ovaries: the increased secretion of luteinizing hormone, a consequence of aberrant hypothalamic gonadotropin-releasing hormone secretion dynamics, and compensatory hyperinsulinemia resulting from insulin resistance. Obesity interacts with polycystic ovary syndrome in multiple ways, but a major role of obesity in its pathophysiology is the exacerbation of insulin resistance. Additionally, obesity contributes to polycystic ovary syndrome by facilitating the conversion of precursor hormones to testosterone within adipose cells. Moreover, obesity can lead to relative hyperandrogenemia, which is marked by lower levels of sex hormone binding globulin and increased availability of free testosterone to target tissues. Also, obesity affects the secretion of gonadotropins, resulting in heightened luteinizing hormone secretion or increased sensitivity of thecal cells to luteinizing hormone. Obesity-related insulin resistance might be amplified by alterations in adipokine and inflammatory cytokine production. Ultimately, obesity and polycystic ovary syndrome might share a common genetic predisposition. The cornerstone of managing polycystic ovary syndrome is to address individual symptoms such as hyperandrogenism (hirsutism, acne, and female type boldness), menstrual irregularities, and infertility stemming from anovulation. However, obesity is integral to the pathophysiology of polycystic ovary syndrome and exacerbates all of its features. Therefore, lifestyle modifications aimed at weight reduction should be the primary strategy in overweight or obese women with polycystic ovary syndrome.The core pathophysiology of polycystic ovary syndrome involves an overproduction of androgens primarily originating from ovarian thecal cells. Two major external triggers promote androgen overproduction in the ovaries: the increased secretion of luteinizing hormone, a consequence of aberrant hypothalamic gonadotropin-releasing hormone secretion dynamics, and compensatory hyperinsulinemia resulting from insulin resistance. Obesity interacts with polycystic ovary syndrome in multiple ways, but a major role of obesity in its pathophysiology is the exacerbation of insulin resistance. Additionally, obesity contributes to polycystic ovary syndrome by facilitating the conversion of precursor hormones to testosterone within adipose cells. Moreover, obesity can lead to relative hyperandrogenemia, which is marked by lower levels of sex hormone binding globulin and increased availability of free testosterone to target tissues. Also, obesity affects the secretion of gonadotropins, resulting in heightened luteinizing hormone secretion or increased sensitivity of thecal cells to luteinizing hormone. Obesity-related insulin resistance might be amplified by alterations in adipokine and inflammatory cytokine production. Ultimately, obesity and polycystic ovary syndrome might share a common genetic predisposition. The cornerstone of managing polycystic ovary syndrome is to address individual symptoms such as hyperandrogenism (hirsutism, acne, and female type boldness), menstrual irregularities, and infertility stemming from anovulation. However, obesity is integral to the pathophysiology of polycystic ovary syndrome and exacerbates all of its features. Therefore, lifestyle modifications aimed at weight reduction should be the primary strategy in overweight or obese women with polycystic ovary syndrome. |
Author | Kim, Jin Ju |
AuthorAffiliation | 2 Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, Korea 1 Department of Obstetrics and Gynecology, Seoul National University Hospital Healthcare System Gangnam Center, Seoul, Korea |
AuthorAffiliation_xml | – name: 2 Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, Korea – name: 1 Department of Obstetrics and Gynecology, Seoul National University Hospital Healthcare System Gangnam Center, Seoul, Korea |
Author_xml | – sequence: 1 givenname: Jin Ju orcidid: 0000-0003-0879-8208 surname: Kim fullname: Kim, Jin Ju organization: Department of Obstetrics and Gynecology, Seoul National University Hospital Healthcare System Gangnam Center, Seoul, Korea, Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, Korea |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39701598$$D View this record in MEDLINE/PubMed https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART003150903$$DAccess content in National Research Foundation of Korea (NRF) |
BookMark | eNpVUUlLAzEUDqJoXS7-AOlFEKGaPZmTlOJSECou55DJoqPTSU2mhfn3povb6YX3Xr7lfftguwmNA-AYwQvBBLx8D1OXMIWEbYEeZlAOcptvb94cE7YHjlKqSkipoAwzvAv2SCEgYoXsgdNJ6VLVdn3d2P5DqDvTpbYy_clCx67_1DU2ZoJDsON1ndzRph6Al5vr59Hd4H5yOx4N7weGkqIdlFo4IgTyRDNEhS0YFRh5gSwsJGHclMRKoWXBpTUCe-04gY4w6ksGjWbkAJyvcZvo1YepVNDVqr4G9RHV8PF5rBDk2SBBeXm8XrZBv6tZrKZZ8urHqhHiq9Ixe6md8l7agiMEqZZ0KcabonSUWYYI4YZnrKs11mxeTp01rmmjrv-B_p801VsWtVAICUgxXqo52yDE8Dl3qVXTKhlX17pxYZ4UyQehEiG6dHnyl-yH5TuV3zOYGFKKzv-sIKiWqavf1MkXPISdHw |
Cites_doi | 10.1210/jc.82.7.2343 10.1210/jcem.85.8.6738 10.1007/s00125-008-1028-6 10.1016/j.fertnstert.2006.05.038 10.1210/endo-126-5-2711 10.2337/db11-1360 10.1677/joe.1.05762 10.1210/jc.2005-1852 10.1093/humupd/dmp024 10.1210/jc.2002-020363 10.1111/ijpo.12110 10.1210/jcem.83.10.5205 10.1093/humrep/deg367 10.1152/ajpendo.2001.281.2.E392 10.1210/jc.2017-02426 10.3389/fendo.2018.00375 10.1210/clinem/dgad463 10.1046/j.1365-2265.1999.00886.x 10.1093/humrep/den089 10.1038/sj.ijo.0801994 10.1210/jc.83.7.2361 10.1016/j.fertnstert.2016.07.1121 10.1111/cen.12784 10.1210/jc.2004-1860 10.1210/jc.2007-1834 10.1210/jc.2005-1457 10.1200/JCO.2016.69.4638 10.1016/j.nut.2012.07.003 10.1210/jc.2005-0691 10.1210/jc.83.6.2001 10.1111/j.1365-2265.2006.02587.x 10.1093/humupd/dml036 10.1210/jcem.79.5.7962325 10.1210/jc.85.7.2434 10.1371/journal.pone.0016390 10.2337/dc07-2190 10.1046/j.1365-2265.2001.01375.x 10.1111/j.1365-2265.1995.tb02665.x 10.1210/jc.2002-020815 10.1186/s12916-020-01861-x 10.1210/jcem-68-1-173 10.1016/S1472-6483(10)61182-0 10.1093/oxfordjournals.humrep.a136243 10.1210/jc.2003-031848 10.1136/adc.2004.053959 10.1111/jog.14132 10.1055/s-2002-38249 10.1210/jc.2003-032046 10.1016/j.jpag.2011.03.002 10.1093/humupd/dmac005 10.1210/jcem-68-6-1027 10.1056/NEJMra041536 10.1210/jc.2009-1908 10.1210/er.2015-1104 10.1177/1179558119874042 10.1210/jc.83.7.2317 10.1210/jc.2012-2937 10.1016/S0039-128X(96)00223-1 10.1016/S0015-0282(16)59293-0 10.1007/s00431-003-1358-9 10.1210/jendso/bvac150.1404 10.1001/jama.2009.2014 10.1530/EJE-20-0862 10.1097/00006254-199906000-00019 10.1007/978-0-387-69248-7_4 10.3109/09513590.2010.508543 10.1210/jc.2005-1329 10.1210/er.2004-0004 10.1186/1741-7015-8-41 10.1038/nrdp.2016.57 10.1530/EJE-21-0287 10.1210/jc.2005-2757 10.1210/jc.2008-0477 10.1111/j.1471-0528.2006.00990.x 10.1111/cen.12441 10.1056/NEJM198903023200904 10.1093/humrep/deq028 10.1111/j.1467-789X.2012.01053.x 10.1038/s41598-023-50650-y 10.1210/jc.2006-2725 10.1093/humrep/der291 10.1007/BF03345743 10.1093/humupd/dmp006 10.1210/jcem.84.11.6148 10.1055/s-2002-38265 10.1172/JCI118126 10.1016/0002-9378(92)91779-A 10.1055/s-2007-1009245 10.4103/jhrs.JHRS_77_17 10.1016/j.molmed.2023.02.006 10.1016/S0303-7207(98)00177-4 10.1016/j.fertnstert.2014.07.004 10.1046/j.1365-2265.1997.2321049.x 10.1093/humrep/deh098 10.1210/me.2004-0178 10.1016/S0889-8529(18)30245-7 10.1210/jc.2003-031122 10.1016/j.jsbmb.2014.06.003 10.1210/jc.84.4.1470 10.1016/j.mce.2008.01.007 10.1111/j.1749-6632.2000.tb06230.x 10.1016/S0015-0282(03)00265-6 10.1016/S2213-8587(22)00339-4 10.1111/j.1365-2265.1992.tb02909.x 10.1210/jc.2009-0545 10.1210/jcem.77.6.8263159 10.1016/j.fertnstert.2014.01.049 10.1093/humrep/den211 10.1095/biolreprod61.4.993 10.1016/j.bbrc.2008.06.039 10.1016/j.molmed.2006.05.006 |
ContentType | Journal Article |
Copyright | Copyright © 2024 Korean Society for the Study of Obesity 2024 |
Copyright_xml | – notice: Copyright © 2024 Korean Society for the Study of Obesity 2024 |
DBID | AAYXX CITATION NPM 7X8 5PM DOA ACYCR |
DOI | 10.7570/jomes24035 |
DatabaseName | CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals Korean Citation Index |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic PubMed |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2508-7576 |
EndPage | 301 |
ExternalDocumentID | oai_kci_go_kr_ARTI_10657631 oai_doaj_org_article_ff8d961104a84d098fc9be45d51336c6 PMC11704221 39701598 10_7570_jomes24035 |
Genre | Journal Article Review |
GroupedDBID | AAYXX ABDBF ACUHS ADBBV ALMA_UNASSIGNED_HOLDINGS AOIJS BCNDV CITATION ESX GROUPED_DOAJ HYE OK1 PGMZT RPM TUS NPM 7X8 5PM M~E ACYCR |
ID | FETCH-LOGICAL-c439t-ba7e3771f3a5147d954721f71d098356cb3d87a8968dc72fae630e354fb50ca53 |
IEDL.DBID | DOA |
ISSN | 2508-6235 2508-7576 |
IngestDate | Fri Jan 24 03:22:38 EST 2025 Wed Aug 27 01:30:34 EDT 2025 Thu Aug 21 18:28:26 EDT 2025 Fri Jul 11 07:31:14 EDT 2025 Sat Jan 11 01:32:05 EST 2025 Tue Jul 01 04:04:52 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Keywords | Obesity Polycystic ovary syndrome Insulin resistance Anovulation |
Language | English |
License | This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c439t-ba7e3771f3a5147d954721f71d098356cb3d87a8968dc72fae630e354fb50ca53 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
ORCID | 0000-0003-0879-8208 |
OpenAccessLink | https://doaj.org/article/ff8d961104a84d098fc9be45d51336c6 |
PMID | 39701598 |
PQID | 3147481145 |
PQPubID | 23479 |
PageCount | 13 |
ParticipantIDs | nrf_kci_oai_kci_go_kr_ARTI_10657631 doaj_primary_oai_doaj_org_article_ff8d961104a84d098fc9be45d51336c6 pubmedcentral_primary_oai_pubmedcentral_nih_gov_11704221 proquest_miscellaneous_3147481145 pubmed_primary_39701598 crossref_primary_10_7570_jomes24035 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2024-12-01 |
PublicationDateYYYYMMDD | 2024-12-01 |
PublicationDate_xml | – month: 12 year: 2024 text: 2024-12-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Korea (South) |
PublicationPlace_xml | – name: Korea (South) |
PublicationTitle | Journal of Obesity & Metabolic Syndrome |
PublicationTitleAlternate | J Obes Metab Syndr |
PublicationYear | 2024 |
Publisher | Korean Society for the Study of Obesity 대한비만학회 |
Publisher_xml | – name: Korean Society for the Study of Obesity – name: 대한비만학회 |
References | ref57 ref56 ref59 ref58 ref53 ref52 ref55 ref54 ref51 ref50 ref46 ref45 ref48 ref47 ref42 ref41 ref44 ref43 ref49 ref8 ref7 ref9 ref4 ref3 ref6 ref5 ref100 ref101 ref40 ref35 ref34 ref37 ref36 ref31 ref30 ref33 ref32 ref39 ref38 ref24 ref23 ref26 ref25 ref20 ref22 ref21 ref28 ref27 ref29 ref13 ref12 ref15 ref14 ref97 ref96 ref11 ref99 ref10 ref98 ref17 ref16 ref19 ref18 ref93 ref92 ref95 ref94 ref91 ref90 ref89 ref86 ref85 ref88 ref87 ref82 ref81 ref84 ref83 ref80 ref79 ref108 ref78 ref109 ref106 ref107 ref75 ref104 ref74 ref105 ref77 ref102 ref76 ref103 ref2 ref1 ref71 ref111 ref70 ref112 ref73 ref72 ref110 ref68 ref67 ref69 ref64 ref63 ref66 ref65 ref60 ref62 ref61 |
References_xml | – ident: ref75 doi: 10.1210/jc.82.7.2343 – ident: ref108 doi: 10.1210/jcem.85.8.6738 – ident: ref80 doi: 10.1007/s00125-008-1028-6 – ident: ref98 doi: 10.1016/j.fertnstert.2006.05.038 – ident: ref72 doi: 10.1210/endo-126-5-2711 – ident: ref43 doi: 10.2337/db11-1360 – ident: ref65 doi: 10.1677/joe.1.05762 – ident: ref95 doi: 10.1210/jc.2005-1852 – ident: ref46 doi: 10.1093/humupd/dmp024 – ident: ref25 doi: 10.1210/jc.2002-020363 – ident: ref93 doi: 10.1111/ijpo.12110 – ident: ref86 doi: 10.1210/jcem.83.10.5205 – ident: ref36 – ident: ref109 doi: 10.1093/humrep/deg367 – ident: ref24 doi: 10.1152/ajpendo.2001.281.2.E392 – ident: ref10 doi: 10.1210/jc.2017-02426 – ident: ref90 doi: 10.3389/fendo.2018.00375 – ident: ref4 doi: 10.1210/clinem/dgad463 – ident: ref50 doi: 10.1046/j.1365-2265.1999.00886.x – ident: ref101 doi: 10.1093/humrep/den089 – ident: ref61 doi: 10.1038/sj.ijo.0801994 – ident: ref100 doi: 10.1210/jc.83.7.2361 – ident: ref45 doi: 10.1016/j.fertnstert.2016.07.1121 – ident: ref44 doi: 10.1111/cen.12784 – ident: ref14 doi: 10.1210/jc.2004-1860 – ident: ref54 doi: 10.1210/jc.2007-1834 – ident: ref38 doi: 10.1210/jc.2005-1457 – ident: ref112 doi: 10.1200/JCO.2016.69.4638 – ident: ref68 doi: 10.1016/j.nut.2012.07.003 – ident: ref16 doi: 10.1210/jc.2005-0691 – ident: ref20 doi: 10.1210/jc.83.6.2001 – ident: ref96 doi: 10.1111/j.1365-2265.2006.02587.x – ident: ref97 doi: 10.1093/humupd/dml036 – ident: ref15 doi: 10.1210/jcem.79.5.7962325 – ident: ref51 doi: 10.1210/jc.85.7.2434 – ident: ref81 doi: 10.1371/journal.pone.0016390 – ident: ref78 doi: 10.2337/dc07-2190 – ident: ref56 doi: 10.1046/j.1365-2265.2001.01375.x – ident: ref28 doi: 10.1111/j.1365-2265.1995.tb02665.x – ident: ref110 doi: 10.1210/jc.2002-020815 – ident: ref103 doi: 10.1186/s12916-020-01861-x – ident: ref105 doi: 10.1210/jcem-68-1-173 – ident: ref111 doi: 10.1016/S1472-6483(10)61182-0 – ident: ref33 doi: 10.1093/oxfordjournals.humrep.a136243 – ident: ref88 doi: 10.1210/jc.2003-031848 – ident: ref89 doi: 10.1136/adc.2004.053959 – ident: ref39 doi: 10.1111/jog.14132 – ident: ref64 doi: 10.1055/s-2002-38249 – ident: ref52 doi: 10.1210/jc.2003-032046 – ident: ref42 doi: 10.1016/j.jpag.2011.03.002 – ident: ref84 doi: 10.1093/humupd/dmac005 – ident: ref22 doi: 10.1210/jcem-68-6-1027 – ident: ref53 doi: 10.1056/NEJMra041536 – ident: ref66 doi: 10.1210/jc.2009-1908 – ident: ref9 doi: 10.1210/er.2015-1104 – ident: ref104 doi: 10.1177/1179558119874042 – ident: ref6 doi: 10.1210/jc.83.7.2317 – ident: ref48 doi: 10.1210/jc.2012-2937 – ident: ref5 doi: 10.1016/S0039-128X(96)00223-1 – ident: ref21 doi: 10.1016/S0015-0282(16)59293-0 – ident: ref87 doi: 10.1007/s00431-003-1358-9 – ident: ref94 doi: 10.1210/jendso/bvac150.1404 – ident: ref31 doi: 10.1001/jama.2009.2014 – ident: ref91 doi: 10.1530/EJE-20-0862 – ident: ref18 doi: 10.1097/00006254-199906000-00019 – ident: ref19 doi: 10.1007/978-0-387-69248-7_4 – ident: ref71 doi: 10.3109/09513590.2010.508543 – ident: ref59 doi: 10.1210/jc.2005-1329 – ident: ref76 doi: 10.1210/er.2004-0004 – ident: ref1 doi: 10.1186/1741-7015-8-41 – ident: ref2 doi: 10.1038/nrdp.2016.57 – ident: ref92 doi: 10.1530/EJE-21-0287 – ident: ref17 doi: 10.1210/jc.2005-2757 – ident: ref77 doi: 10.1210/jc.2008-0477 – ident: ref62 doi: 10.1111/j.1471-0528.2006.00990.x – ident: ref67 doi: 10.1111/cen.12441 – ident: ref11 doi: 10.1056/NEJM198903023200904 – ident: ref41 doi: 10.1093/humrep/deq028 – ident: ref99 doi: 10.1111/j.1467-789X.2012.01053.x – ident: ref37 doi: 10.1038/s41598-023-50650-y – ident: ref47 doi: 10.1210/jc.2006-2725 – ident: ref7 doi: 10.1093/humrep/der291 – ident: ref34 doi: 10.1007/BF03345743 – ident: ref69 doi: 10.1093/humupd/dmp006 – ident: ref49 doi: 10.1210/jcem.84.11.6148 – ident: ref63 doi: 10.1055/s-2002-38265 – ident: ref23 doi: 10.1172/JCI118126 – ident: ref40 doi: 10.1016/0002-9378(92)91779-A – ident: ref55 doi: 10.1055/s-2007-1009245 – ident: ref60 doi: 10.4103/jhrs.JHRS_77_17 – ident: ref83 doi: 10.1016/j.molmed.2023.02.006 – ident: ref29 doi: 10.1016/S0303-7207(98)00177-4 – ident: ref82 doi: 10.1016/j.fertnstert.2014.07.004 – ident: ref12 doi: 10.1046/j.1365-2265.1997.2321049.x – ident: ref3 doi: 10.1093/humrep/deh098 – ident: ref13 doi: 10.1210/me.2004-0178 – ident: ref27 doi: 10.1016/S0889-8529(18)30245-7 – ident: ref30 doi: 10.1210/jc.2003-031122 – ident: ref8 doi: 10.1016/j.jsbmb.2014.06.003 – ident: ref107 doi: 10.1210/jc.84.4.1470 – ident: ref70 doi: 10.1016/j.mce.2008.01.007 – ident: ref32 doi: 10.1111/j.1749-6632.2000.tb06230.x – ident: ref57 doi: 10.1016/S0015-0282(03)00265-6 – ident: ref85 doi: 10.1016/S2213-8587(22)00339-4 – ident: ref106 doi: 10.1111/j.1365-2265.1992.tb02909.x – ident: ref102 doi: 10.1210/jc.2009-0545 – ident: ref74 doi: 10.1210/jcem.77.6.8263159 – ident: ref35 doi: 10.1016/j.fertnstert.2014.01.049 – ident: ref58 doi: 10.1093/humrep/den211 – ident: ref73 doi: 10.1095/biolreprod61.4.993 – ident: ref79 doi: 10.1016/j.bbrc.2008.06.039 – ident: ref26 doi: 10.1016/j.molmed.2006.05.006 |
SSID | ssib044745252 ssj0002039626 |
Score | 2.2942173 |
SecondaryResourceType | review_article |
Snippet | The core pathophysiology of polycystic ovary syndrome involves an overproduction of androgens primarily originating from ovarian thecal cells. Two major... |
SourceID | nrf doaj pubmedcentral proquest pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | 289 |
SubjectTerms | anovulation insulin resistance obesity polycystic ovary syndrome Review 가정의학 |
Title | Obesity and Polycystic Ovary Syndrome |
URI | https://www.ncbi.nlm.nih.gov/pubmed/39701598 https://www.proquest.com/docview/3147481145 https://pubmed.ncbi.nlm.nih.gov/PMC11704221 https://doaj.org/article/ff8d961104a84d098fc9be45d51336c6 https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART003150903 |
Volume | 33 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | Journal of Obesity & Metabolic Syndrome, 2024, 33(4), 114, pp.289-301 |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3LSuRAFC0G3cxGHJxHq9NkmHEZrKTey261UcEZQQV3RT19tCbStgO9mW_3VhK1WwQ3s0kgD3JzbsE5l6o6F6FfSvqAqSW5kzLmtAwiV8TwHKQDKWJM2xnTbuSj33z_jB6es_O5Vl9pTVhrD9wCtx2j9IoDSVEjqcdKRqdsoMynxiTcNWbbWOG5YgpGEqUizdelKQSgeJkDx7PWm1Qwgbev69twn4zo2AIbNab9wDHVJL6lN18vm5zjodEqWukEZDZoA_-EPoRqDW11_v6ZqXx2XN_M3Cz5L2d__prJLDvpXAk-o7PR3unOft41QMgd6IRpbo0IRIgiEgO6RnjFKBRsURQJB8K4s8RLYaTi0jtRRhM4wYEwGi3DzjDyBS1VdRW-oQxkjC0Nx4S4SEtsbCSgPAwQPvYx2thDP5-A0Hetz4WG-iDBpV_g6qFhwuj5ieRN3VyAjOkuY_q9jMGnAGE9dlfN--l8UevxRIOCP4CPciiBSNFDP54yoGHEp2kMU4X64V4TgIJKqOMgnK9tRp4DAnUF-kbJHpILuVqIePFOdXXZuGqnFjy0LIv1__GPG-hjCeqnXfeyiZamk4fwHdTL1PbR8mC4Oxz1mwELx6N_e4_JsO1B |
linkProvider | Directory of Open Access Journals |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Obesity+and+Polycystic+Ovary+Syndrome&rft.jtitle=Journal+of+Obesity+%26+Metabolic+Syndrome&rft.au=Jin+Ju+Kim&rft.date=2024-12-01&rft.pub=Korean+Society+for+the+Study+of+Obesity&rft.issn=2508-6235&rft.volume=33&rft.issue=4&rft.spage=289&rft.epage=301&rft_id=info:doi/10.7570%2Fjomes24035&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_ff8d961104a84d098fc9be45d51336c6 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2508-6235&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2508-6235&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2508-6235&client=summon |